ImageneBio, Inc. (formerly Ikena Oncology, Inc.) is a clinical-stage biopharmaceutical company focused on developing IMG-007 for immunological and inflammatory indications, including atopic dermatitis (AD). The company completed a merger with Inmagene Biopharmaceuticals on July 25, 2025, and subsequently changed its name. IMG-007 is its sole product candidate, with development dependent on third-party manufacturers and licensed intellectual property.
Q2 FY2026 — expected 2026-08-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-10 | 2025-12-31 | 0001193125-26-099434 | EDGAR | 101K words |
| 2025-03-06 | 2024-12-31 | 0000950170-25-034188 | EDGAR | 103K words |
| 2024-03-12 | 2023-12-31 | 0000950170-24-029651 | EDGAR | 98K words |
| 2023-03-14 | 2022-12-31 | 0000950170-23-007681 | EDGAR | 101K words |
| 2022-03-17 | 2021-12-31 | 0000950170-22-003998 | EDGAR | 101K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001193125-26-333920 | EDGAR | 66K words |
| 2025-11-12 | 2025-09-30 | 0001193125-25-275932 | EDGAR | 74K words |
| 2025-07-24 | 2025-06-30 | 0000950170-25-098414 | EDGAR | 64K words |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066411 | EDGAR | 61K words |
| 2024-11-07 | 2024-09-30 | 0000950170-24-122818 | EDGAR | 61K words |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093880 | EDGAR | 61K words |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058715 | EDGAR | 57K words |
| 2023-11-09 | 2023-09-30 | 0000950170-23-061535 | EDGAR | 66K words |
| 2023-08-10 | 2023-06-30 | 0000950170-23-040943 | EDGAR | 63K words |
| 2023-05-15 | 2023-03-31 | 0000950170-23-021909 | EDGAR | 61K words |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022323 | EDGAR | 64K words |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016600 | EDGAR | 64K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001193125-26-333912 | EDGAR | 3K words |
| 2026-07-23 | 0001193125-26-314167 | EDGAR | 7K words |
| 2026-03-17 | 0001193125-26-110945 | EDGAR | 1K words |
| 2026-03-10 | 0001193125-26-099422 | EDGAR | 3K words |
| 2026-02-17 | 0001193125-26-054684 | EDGAR | 1K words |
| 2025-12-18 | 0001193125-25-324798 | EDGAR | 1K words |
| 2025-11-19 | 0001193125-25-286984 | EDGAR | 4K words |
| 2025-11-12 | 0001193125-25-275910 | EDGAR | 4K words |
| 2025-11-05 | 0001193125-25-266889 | EDGAR | 1K words |
| 2025-10-29 | 0001193125-25-254697 | EDGAR | 1K words |
82 total filings indexed. 55 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001835579 |
| Ticker | IMA |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.imagenebio.com |
| Listed | 2025-07-28 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IMA (~200 tokens, structured JSON with cryptographic provenance)